We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Drugs » Quality

Quality
Quality RSS Feed RSS

Apotex Recalls Six Lots of Ophthalmic Solution Because of Cracked Bottle Caps

March 7, 2023
The affected lots were distributed in the U.S. between April 5, 2022 and Feb. 22. Read More

FDA Warns That Energy Supplement Contains Active Cialis Ingredient

February 6, 2023
The product is sold on Amazon.com and “possibly in some retail stores,” the agency said. Read More

Hospira Issues Nationwide Recall of Propofol Lot

August 25, 2022
Pfizer has not received reports of any adverse events associated with this issue for the lot so far. Read More

Teva Recalls Two Lots of Matzim LA for Failed Dissolution Specifications

August 18, 2022
No reports of adverse events have been reported, the company said. Read More

Merck’s Type 2 Diabetes Drugs Potentially Contaminated With Nitrosamines

August 11, 2022
Patients are advised to continue taking these drugs when clinically appropriate, the agency said. Read More

Hospira Recalls Propofol Injectable Emulsion Lot Due to Potential Particulate Risk

July 19, 2022
Hospira has not received any reports of adverse events associated with this issue for the specific lot. Read More

Mylan Recalls Batch of Insulin Pens Due to Missing Label Risk

July 8, 2022
The affected batch was distributed between April 4 and May 5 of this year. Read More

Vizient and RISCS Join Forces Over Pharma Supply Chain Pilot

May 11, 2022
The pilot program will analyze data from pharmacy suppliers and consider such supply chain issues as available production capacity, flexibility and geopolitical risks. Read More

Pfizer Recalls Blood Pressure and Heart Failure Drug Accupril Due to Nitrosamine Content

April 26, 2022
Pfizer said that no adverse events have been reported relating to the recalled products. Read More

Academics, Pharmacists Call for Drug Quality Rating System

June 2, 2020
A group of U.S. academics and pharmacists has proposed a quality rating system for prescription drugs that would allow bulk buyers to assess the quality of drugs before they make purchases. Read More

Academics, Pharmacists Call for Drug Quality Rating System

June 2, 2020
A group of U.S. academics and pharmacists has proposed a quality rating system for prescription drugs that would allow bulk buyers to assess the quality of drugs before they make purchases. Read More

CDER Outlines CGMPs — and Exemptions — for Outsourcing Facilities

February 3, 2020
CDER spelled out current good manufacturing practices for drug compounders that register as outsourcers in a new draft guidance — and noted when the FDA does not intend to take regulatory action. Read More
Previous 1 2 3 4 5 6 7 8 9 … 97 98 Next

Upcoming Events

  • 28Sep

    The Cost of Counterfeiting: Why You Need a Plan to Secure Your Medical Device Supply Chain

  • 28Sep

    Calculating Sample Size to Satisfy FDA Expectations

  • 11Oct

    GMP Quality Management vSummit 2023: Where Quality Meets Risk

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

  • 02Nov

    How UDI and UDI Data Can — and Must — Be Used for More Than Just Device Identification

Featured Products

  • FDA, FTC and DOJ Enforcement of Medical Device Regulations

    FDA, FTC and DOJ Enforcement of Medical Device Regulations

  • Using Real-World Evidence in Drug and Device Submissions

    Using Real-World Evidence in Drug and Device Submissions

Featured Stories

  • Expert Says FDA Under No Obligation to Educate Companies on Inspection Rights

  • FDA Deems Hamilton Ventilator Recall Class I for Software Issue Causing Device to Stop

  • Survey Shows Nearly All Pharm Techs Face Drug Shortages, Pfizer Plant Shortages Continue Until 2024

  • FDA Shares Premarket Requirements for Device Cybersecurity in Final Guidance

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing